Meeting Wed, 10/19/2022 - 12:00 Drug Utilization Review Board Meeting Information

Date
Media
Edit Implementation Schedule October 2022
New Drugs and Edits with No Annual Changes October 2022
PDL Announcement October 2022
PDL Recommendations October 2022
Missouri DUR Board Retrospective - DUR Interventions October 2022
MO Healthnet Pharmacy Program and Budget Update October 2022
Preventing Overdose in Patients Using Medication-Assisted Treatment October 2022
Agenda
DUR Agenda October 2022
Minutes
DUR Minutes October 2022
Criteria
DUR Criteria
Conduent Reports
Media
Conduent Reports October 2022
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
Entresto October 2022
SMA October 2022
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
Alpelisib October 2022
ATTR October 2022
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
ACEI_ACEI-Diuretic Combinations October 2022
ACEI_CCB Combinations October 2022
ADHD, Methylphenidate SA October 2022
ADHD, Non-Stimulants October 2022
Alpha Glucosidase Inhibitors October 2022
Amylin Analogs October 2022
Antibiotics, Mupirocin Topical October 2022
Antihyperuricemic Agents October 2022
ARB_ARB-Diuretic Combos October 2022
ARB-CCB Combos October 2022
BB_BB-Diuretic Combos October 2022
Benign Prostatic Hyperplasia (BPH) Agents October 2022
Biguanides and Combination Agents October 2022
Bone Ossification Agents October 2022
CCB, Non-DHP October 2022
Cephalosporins October 2022
Direct Renin Inhibitors and Combos October 2022
DPPIV Inhibitors October 2022
Electrolyte Depleting Agents, Phosphate Lowering October 2022
Fluoroquinolones, Oral October 2022
Homozygous Familial Hypercholesterolemia (HoFH) October 2022
Insulin, Mixed October 2022
Insulin, Non-Analogs October 2022
Insulin, Rapid Acting October 2022
Macrolides October 2022
Methotrexate Agents October 2022
Niacin Derivatives October 2022
PAH, ETRAs October 2022
PAH, PDE5-SGC October 2022
PAH, Prostacyclins Oral October 2022
Penicillins October 2022
SGLT2 Inhibitors October 2022
Statins and Combos October 2022
Sulfonylurea Agents, Second Generation October 2022
Tetracyclines October 2022
Thiazolidinediones and Combinations October 2022
Thrombocytopenia Agents October 2022
Triglyceride Lowering Agents October 2022
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
ADHD, Amphetamines Long Acting October 2022
ADHD, Amphetamines Short Acting October 2022
ADHD, Methylphenidate Long Acting October 2022
Antibiotics, GI Oral October 2022
Antibiotics, Vaginal October 2022
Anticoagulants, Oral and Subcutaneous October 2022
Anticonvulsants, Rescue Agents October 2022
Bile Salt Agents October 2022
CCB, DHP October 2022
Colony Stimulating Factors October 2022
Cryopyrin-Associated Periodic Syndrome (CAPS) October 2022
Dry Eye Disease Agents October 2022
Electrolyte Depleting Agents, Potassium Lowering October 2022
Erythropoiesis Stimulating Agents October 2022
GLP-1 Receptor Agonists and Combination Agents October 2022
Growth Hormone Agents, Somatropin October 2022
Growth Hormone and Growth Hormone Releasing Factors, Select Agents October 2022
Insulin, Long Acting October 2022
LHRH, GnRH Agents, Non-Oral October 2022
LHRH, GnRH Agents, Oral October 2022
Multiple Sclerosis Agents, Injectable October 2022
PAH, Prostacyclins Inhaled October 2022
PAH, Prostacyclins Injectable October 2022
PCSK9 Inhibitor October 2022
Proton Pump Inhibitors (PPIs) October 2022
Sympatholytics October 2022
Targeted Immune Modulators JAK Inhibitors October 2022
Targeted Immune Modulators, IL6 Receptor Inhibitors October 2022
Targeted Immune Modulators, IL17 Receptor Antagonists October 2022
Targeted Immune Modulators, IL23-12 Inhibitors October 2022
Targeted Immune Modulators, Misc Allergy and Asthma Related Monoclonal Antibodies October 2022
Targeted Immune Modulators, Select Agents October 2022
Targeted Immune Modulators, TNF Inhibitors October 2022
Urinary Tract Antispasmodics September 2022
Page
Drug Utilization Review Board Meeting Information